Skip to main content
Live · TradingView
Back to the NewsWire

Psychiatrist

Published September 29, 2026 · Updated September 30, 2026

Two Investigational Paths in GAD: Company-Reported Results on DT120 ODT and SNTX-2643

Read the full story at Psychiatrist

Investigational Psychedelic Data Are Emerging, but FDA Approval Is Still Required ... Press release . August 12, 2026. Definium Therapeutics. Definium.

Surfaced by this Google Alert

  • Psychedelic press release